Powerful new weight-loss medications are in the works to treat obesity. Doctors explain why more options are needed and the ...

Today, we discuss Trump’s lofty new health plan, see the FDA delay two drug reviews under the new voucher program, and more.

A new obesity drug that Eli Lilly is researching but hasn't approved is turning up online, even though it's not supposed to be available.

Eli Lilly (LLY) stock slips as the FDA decision on the company's obesity pill orforglipron is now due in April, which ...